Amcor vs Crown
AMCR and CCK side by side. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How AMCR and CCK compare
Amcor is the larger company, worth 1.7 times as much as Crown ($21.9B against $13.0B).
On earnings, Crown is cheaper: it trades at 17.2× trailing earnings, against 19.9× for Amcor.
Amcor grew revenue faster over the last twelve months (56.6% versus 10.3% for Crown).
Crown keeps more of each dollar of sales as profit, with a net margin of 5.9% compared with 4.7% at Amcor.
Both pay dividends: Amcor yields 5.5% and Crown 1.1%.
Crown scores higher on the StockData Score (19 against 14 for Amcor), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | AMCR | CCK |
|---|---|---|
| Size and price | ||
| Market cap | $21.9B | $13.0B |
| Share price | $47.39 | $119.24 |
| Change, 1 year | 18.5% | 24.9% |
| Change, 5 years | −21.9% | 11.5% |
| Beta (5Y) | 0.60 | 0.66 |
| Employees | 75K | 23K |
| StockData Score | ||
| Total score | 14 | 19 (better) |
| Valuation score | 3 | 4 (better) |
| Growth score | 4 (better) | 3 |
| Performance score | 2 | 5 (better) |
| Health score | 2 | 3 (better) |
| Dividend score | 3 | 4 (better) |
| Valuation | ||
| P/E | 19.9× | 17.2× (better) |
| P/S | 0.9× (better) | 1.0× |
| P/B | 1.9× (better) | 4.5× |
| EV/EBITDA | 10.3× (better) | 11.6× |
| P/FCF | 17.8× | 10.8× (better) |
| PEG | – | 8.07 |
| FCF yield | 5.6% | 9.2% (better) |
| Fair value | $48.42 | $138.61 |
| Margin of safety | 2.1% | 14.0% (better) |
| Growth | ||
| Revenue growth (TTM) | 56.6% (better) | 10.3% |
| Revenue growth, 5Y average | 12.8% (better) | 5.7% |
| Net income growth (TTM) | 116% (better) | 40.8% |
| EPS growth (TTM) | 48.8% (better) | 46.0% |
| EPS growth, 5Y average | −4.6% | 8.2% (better) |
| Profitability | ||
| Gross margin | 20.0% | 21.0% (better) |
| Operating margin | 8.1% | 12.3% (better) |
| Net margin | 4.7% | 5.9% (better) |
| FCF margin | 5.2% | 9.0% (better) |
| Return on equity | 9.4% | 27.2% (better) |
| Return on invested capital | 6.6% | 14.6% (better) |
| Financial health | ||
| Debt / equity | 1.19 (better) | 2.11 |
| Net debt / EBITDA | 3.82 | 3.32 (better) |
| Interest coverage | 2.8× | 4.1× (better) |
| Current ratio | 1.25 (better) | 1.05 |
| Altman Z-score | 1.40 | 1.99 (better) |
| Piotroski F-score | 6 | 8 (better) |
| Dividends and buybacks | ||
| Dividend yield | 5.5% (better) | 1.1% |
| Payout ratio | 108% | 17.5% |
| Years of dividend growth | 6 (better) | 4 |
| Dividend growth, 5Y average | 2.1% | – |
| Buyback yield | −0.02% | 6.3% (better) |
| Shareholder yield | 5.5% | 7.4% (better) |
| Ownership | ||
| Held by institutions | – | 99.3% |
| Held by insiders | 0.68% | 0.96% |
| Insider net buying, 12 months | $2.6M (better) | −$16.5M |
| Superinvestors holding | – | 3 |
| Short interest, % of float | – | 2.4% |
Go deeper
- AMCR stock overview
- AMCR income statement
- AMCR valuation and score
- CCK stock overview
- CCK income statement
- CCK valuation and score
Other comparisons
For information only, not investment advice. Check the source filings before relying on any figure.